"Methyldopa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.
| Descriptor ID |
D008750
|
| MeSH Number(s) |
D02.092.311.200.538 D12.125.072.050.685.400.600 D12.125.072.050.875.130.600
|
| Concept/Terms |
Methyldopa- Methyldopa
- alpha-Methyl-L-Dopa
- alpha Methyl L Dopa
- alpha-Methyldopa
- alpha Methyldopa
- Alphamethyldopa
|
Below are MeSH descriptors whose meaning is more general than "Methyldopa".
Below are MeSH descriptors whose meaning is more specific than "Methyldopa".
This graph shows the total number of publications written about "Methyldopa" by people in this website by year, and whether "Methyldopa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methyldopa" by people in Profiles.
-
Masood U, Venturini N, Nicoletti P, Dellinger A, Kleiner D, Bonkovsky HL, Barnhart H, Vuppalanchi R, Rossi S, Odin JA, Kushner T. Drug-Induced Liver Injury in Pregnancy: The U.S. Drug-Induced Liver Injury Network Experience. Obstet Gynecol. 2024 Jun 01; 143(6):819-823.
-
Barnea ER, Fakih H, Oelsner G, Walner S, DeCherney AH, Naftolin F. Effect of antihypertensive drugs on catechol-O-methyltransferase and monoamine oxidase activity in human term placental explants. Gynecol Obstet Invest. 1986; 21(3):124-30.
-
May CA, Vlasses PH, Rocci ML, Rotmensch HH, Swanson BN, Tannenbaum RP, Ferguson RK, Abrams WB. Methyldopa does not alter the disposition of digoxin. J Clin Pharmacol. 1984 Aug-Sep; 24(8-9):386-9.
-
Wallin JD, Wilson D, Winer N, Maronde RF, Michelson EL, Langford H, Maloy J, Poland M. Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trial. Am J Med. 1983 Oct 17; 75(4A):87-94.
-
Rosenthal L, Affrime MB, Lowenthal DT, Falkner B, Saris S, Gould AB. Biochemical and dynamic responses to single and repeated doses of methyldopa and propranolol during dynamic physical activity. Clin Pharmacol Ther. 1982 Dec; 32(6):701-10.
-
Lowenthal DT, Affrime MB, Falkner B, Saris S, Hakki H, Rosenthal L. Potassium disposition and neuroendocrine effects of propranolol, methyldopa and clonidine during dynamic exercise. Clin Exp Hypertens A. 1982; 4(9-10):1895-911.
-
Gerson IM, Friedman R, Unterberger H. Non-antagonism of antiadrenergic agents by a dibenzoxepine. (Preliminary report). Dis Nerv Syst. 1970 Nov; 31(11):780-2.
-
LAIBSON PR, LEOPOLD IH. Intraocular pressure studies with alpha-methyl-dopa. Arch Ophthalmol. 1962 Nov; 68:648-50.